Interleukin-19 in Breast Cancer

Inflammatory cytokines within the tumor microenvironment are linked to progression in breast cancer. Interleukin- (IL-) 19, part of the IL-10 family, contributes to a range of diseases and disorders, such as asthma, endotoxic shock, uremia, psoriasis, and rheumatoid arthritis. IL-19 is expressed in...

Full description

Saved in:
Bibliographic Details
Published in:Clinical & developmental immunology 2013-01, Vol.2013 (2013), p.1-9
Main Authors: Chang, Ming-Shi, Yeh, Ching-Hua, Li, Chien-Feng, Chen, Ying-Yin, Hsing, Chung-Hsi
Format: Article
Language:English
Subjects:
Biomarkers - metabolism
Breast cancer
Breast Neoplasms - diagnosis
Breast Neoplasms - immunology
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Carcinoma, Ductal, Breast - diagnosis
Carcinoma, Ductal, Breast - immunology
Carcinoma, Ductal, Breast - mortality
Carcinoma, Ductal, Breast - pathology
Cell Movement
Cell Proliferation
Colleges & universities
Disease Progression
Female
Gene Expression
Humans
Immunology
Interleukins - genetics
Interleukins - immunology
Neoplasm Metastasis
Prognosis
Review
Rodents
Survival Analysis
Tumor Microenvironment - immunology
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c664t-f58ff7aaf88b6e6c81fe3d80e90ea047fb13b4e9a16ada362d573099a25392d83
cites cdi_FETCH-LOGICAL-c664t-f58ff7aaf88b6e6c81fe3d80e90ea047fb13b4e9a16ada362d573099a25392d83
container_end_page 9
container_issue 2013
container_start_page 1
container_title Clinical & developmental immunology
container_volume 2013
creator Chang, Ming-Shi
Yeh, Ching-Hua
Li, Chien-Feng
Chen, Ying-Yin
Hsing, Chung-Hsi
description Inflammatory cytokines within the tumor microenvironment are linked to progression in breast cancer. Interleukin- (IL-) 19, part of the IL-10 family, contributes to a range of diseases and disorders, such as asthma, endotoxic shock, uremia, psoriasis, and rheumatoid arthritis. IL-19 is expressed in several types of tumor cells, especially in squamous cell carcinoma of the skin, tongue, esophagus, and lung and invasive duct carcinoma of the breast. In breast cancer, IL-19 expression is correlated with increased mitotic figures, advanced tumor stage, higher metastasis, and poor survival. The mechanisms of IL-19 in breast cancer have recently been explored both in vitro and in vivo. IL-19 has an autocrine effect in breast cancer cells. It directly promotes proliferation and migration and indirectly provides a microenvironment for tumor progression, which suggests that IL-19 is a prognostic marker in breast cancer and that antagonizing IL-19 may have therapeutic potential.
doi_str_mv 10.1155/2013/294320
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_06f30df2f2eb4e25a94377784c85751e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_06f30df2f2eb4e25a94377784c85751e</doaj_id><sourcerecordid>1508758755</sourcerecordid><originalsourceid>FETCH-LOGICAL-c664t-f58ff7aaf88b6e6c81fe3d80e90ea047fb13b4e9a16ada362d573099a25392d83</originalsourceid><addsrcrecordid>eNqNkctrFTEUh4NYbKldudcLbooyNu_HRmgvPi4U3Og6nJk5aVPnZmoyo_jfN3WupXVTIZBw8vFxzvkR8oLRd4wpdcIpEyfcScHpE3LABZONYUo_3b2t1WyfHJUSW6qoEUJb_Yzsc2EY5ZQekFebNGEecP4eU8PcKqbVWUYo02oNqcP8nOwFGAoe7e5D8u3jh6_rz835l0-b9el502ktpyYoG4IBCNa2GnVnWUDRW4qOIlBpQstEK9EB09CD0LxXRlDngCvheG_FIdks3n6EK3-d4xbybz9C9H8KY77wkKfYDeipDoL2gQeOVckV1OmNMVZ2VhnFsLreL67rud1i32GaMgwPpA9_Urz0F-NPL7SS2pgqON4J8vhjxjL5bSwdDgMkHOfimaLWqHrU46hQWjjJjavo63_Qq3HOqW7VM8ktZcwIXam3C9XlsZSM4a5vRv1t5P42cr9EXumX90e9Y_8GXIE3C3AZUw-_4v_ZsCIY4B5MtXJc3ADR_Lj5</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1428011736</pqid></control><display><type>article</type><title>Interleukin-19 in Breast Cancer</title><source>PubMed Central database</source><source>Wiley Open Access</source><source>ProQuest Publicly Available Content database</source><creator>Chang, Ming-Shi ; Yeh, Ching-Hua ; Li, Chien-Feng ; Chen, Ying-Yin ; Hsing, Chung-Hsi</creator><contributor>Rezaei, Nima</contributor><creatorcontrib>Chang, Ming-Shi ; Yeh, Ching-Hua ; Li, Chien-Feng ; Chen, Ying-Yin ; Hsing, Chung-Hsi ; Rezaei, Nima</creatorcontrib><description>Inflammatory cytokines within the tumor microenvironment are linked to progression in breast cancer. Interleukin- (IL-) 19, part of the IL-10 family, contributes to a range of diseases and disorders, such as asthma, endotoxic shock, uremia, psoriasis, and rheumatoid arthritis. IL-19 is expressed in several types of tumor cells, especially in squamous cell carcinoma of the skin, tongue, esophagus, and lung and invasive duct carcinoma of the breast. In breast cancer, IL-19 expression is correlated with increased mitotic figures, advanced tumor stage, higher metastasis, and poor survival. The mechanisms of IL-19 in breast cancer have recently been explored both in vitro and in vivo. IL-19 has an autocrine effect in breast cancer cells. It directly promotes proliferation and migration and indirectly provides a microenvironment for tumor progression, which suggests that IL-19 is a prognostic marker in breast cancer and that antagonizing IL-19 may have therapeutic potential.</description><identifier>ISSN: 2314-8861</identifier><identifier>ISSN: 1740-2522</identifier><identifier>EISSN: 2314-7156</identifier><identifier>EISSN: 1740-2530</identifier><identifier>DOI: 10.1155/2013/294320</identifier><identifier>PMID: 23710200</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Biomarkers - metabolism ; Breast cancer ; Breast Neoplasms - diagnosis ; Breast Neoplasms - immunology ; Breast Neoplasms - mortality ; Breast Neoplasms - pathology ; Carcinoma, Ductal, Breast - diagnosis ; Carcinoma, Ductal, Breast - immunology ; Carcinoma, Ductal, Breast - mortality ; Carcinoma, Ductal, Breast - pathology ; Cell Movement ; Cell Proliferation ; Colleges &amp; universities ; Disease Progression ; Female ; Gene Expression ; Humans ; Immunology ; Interleukins - genetics ; Interleukins - immunology ; Neoplasm Metastasis ; Prognosis ; Review ; Rodents ; Survival Analysis ; Tumor Microenvironment - immunology ; Tumors</subject><ispartof>Clinical &amp; developmental immunology, 2013-01, Vol.2013 (2013), p.1-9</ispartof><rights>Copyright © 2013 Ying-Yin Chen et al.</rights><rights>Copyright © 2013 Ying-Yin Chen et al. Ying-Yin Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2013 Ying-Yin Chen et al. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c664t-f58ff7aaf88b6e6c81fe3d80e90ea047fb13b4e9a16ada362d573099a25392d83</citedby><cites>FETCH-LOGICAL-c664t-f58ff7aaf88b6e6c81fe3d80e90ea047fb13b4e9a16ada362d573099a25392d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1428011736/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1428011736?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23710200$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Rezaei, Nima</contributor><creatorcontrib>Chang, Ming-Shi</creatorcontrib><creatorcontrib>Yeh, Ching-Hua</creatorcontrib><creatorcontrib>Li, Chien-Feng</creatorcontrib><creatorcontrib>Chen, Ying-Yin</creatorcontrib><creatorcontrib>Hsing, Chung-Hsi</creatorcontrib><title>Interleukin-19 in Breast Cancer</title><title>Clinical &amp; developmental immunology</title><addtitle>Clin Dev Immunol</addtitle><description>Inflammatory cytokines within the tumor microenvironment are linked to progression in breast cancer. Interleukin- (IL-) 19, part of the IL-10 family, contributes to a range of diseases and disorders, such as asthma, endotoxic shock, uremia, psoriasis, and rheumatoid arthritis. IL-19 is expressed in several types of tumor cells, especially in squamous cell carcinoma of the skin, tongue, esophagus, and lung and invasive duct carcinoma of the breast. In breast cancer, IL-19 expression is correlated with increased mitotic figures, advanced tumor stage, higher metastasis, and poor survival. The mechanisms of IL-19 in breast cancer have recently been explored both in vitro and in vivo. IL-19 has an autocrine effect in breast cancer cells. It directly promotes proliferation and migration and indirectly provides a microenvironment for tumor progression, which suggests that IL-19 is a prognostic marker in breast cancer and that antagonizing IL-19 may have therapeutic potential.</description><subject>Biomarkers - metabolism</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - immunology</subject><subject>Breast Neoplasms - mortality</subject><subject>Breast Neoplasms - pathology</subject><subject>Carcinoma, Ductal, Breast - diagnosis</subject><subject>Carcinoma, Ductal, Breast - immunology</subject><subject>Carcinoma, Ductal, Breast - mortality</subject><subject>Carcinoma, Ductal, Breast - pathology</subject><subject>Cell Movement</subject><subject>Cell Proliferation</subject><subject>Colleges &amp; universities</subject><subject>Disease Progression</subject><subject>Female</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Immunology</subject><subject>Interleukins - genetics</subject><subject>Interleukins - immunology</subject><subject>Neoplasm Metastasis</subject><subject>Prognosis</subject><subject>Review</subject><subject>Rodents</subject><subject>Survival Analysis</subject><subject>Tumor Microenvironment - immunology</subject><subject>Tumors</subject><issn>2314-8861</issn><issn>1740-2522</issn><issn>2314-7156</issn><issn>1740-2530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkctrFTEUh4NYbKldudcLbooyNu_HRmgvPi4U3Og6nJk5aVPnZmoyo_jfN3WupXVTIZBw8vFxzvkR8oLRd4wpdcIpEyfcScHpE3LABZONYUo_3b2t1WyfHJUSW6qoEUJb_Yzsc2EY5ZQekFebNGEecP4eU8PcKqbVWUYo02oNqcP8nOwFGAoe7e5D8u3jh6_rz835l0-b9el502ktpyYoG4IBCNa2GnVnWUDRW4qOIlBpQstEK9EB09CD0LxXRlDngCvheG_FIdks3n6EK3-d4xbybz9C9H8KY77wkKfYDeipDoL2gQeOVckV1OmNMVZ2VhnFsLreL67rud1i32GaMgwPpA9_Urz0F-NPL7SS2pgqON4J8vhjxjL5bSwdDgMkHOfimaLWqHrU46hQWjjJjavo63_Qq3HOqW7VM8ktZcwIXam3C9XlsZSM4a5vRv1t5P42cr9EXumX90e9Y_8GXIE3C3AZUw-_4v_ZsCIY4B5MtXJc3ADR_Lj5</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Chang, Ming-Shi</creator><creator>Yeh, Ching-Hua</creator><creator>Li, Chien-Feng</creator><creator>Chen, Ying-Yin</creator><creator>Hsing, Chung-Hsi</creator><general>Hindawi Publishing Corporation</general><general>Hindawi Limited</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>CWDGH</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20130101</creationdate><title>Interleukin-19 in Breast Cancer</title><author>Chang, Ming-Shi ; Yeh, Ching-Hua ; Li, Chien-Feng ; Chen, Ying-Yin ; Hsing, Chung-Hsi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c664t-f58ff7aaf88b6e6c81fe3d80e90ea047fb13b4e9a16ada362d573099a25392d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biomarkers - metabolism</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - immunology</topic><topic>Breast Neoplasms - mortality</topic><topic>Breast Neoplasms - pathology</topic><topic>Carcinoma, Ductal, Breast - diagnosis</topic><topic>Carcinoma, Ductal, Breast - immunology</topic><topic>Carcinoma, Ductal, Breast - mortality</topic><topic>Carcinoma, Ductal, Breast - pathology</topic><topic>Cell Movement</topic><topic>Cell Proliferation</topic><topic>Colleges &amp; universities</topic><topic>Disease Progression</topic><topic>Female</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Immunology</topic><topic>Interleukins - genetics</topic><topic>Interleukins - immunology</topic><topic>Neoplasm Metastasis</topic><topic>Prognosis</topic><topic>Review</topic><topic>Rodents</topic><topic>Survival Analysis</topic><topic>Tumor Microenvironment - immunology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chang, Ming-Shi</creatorcontrib><creatorcontrib>Yeh, Ching-Hua</creatorcontrib><creatorcontrib>Li, Chien-Feng</creatorcontrib><creatorcontrib>Chen, Ying-Yin</creatorcontrib><creatorcontrib>Hsing, Chung-Hsi</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Middle East &amp; Africa Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest Publicly Available Content database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals at publisher websites</collection><jtitle>Clinical &amp; developmental immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chang, Ming-Shi</au><au>Yeh, Ching-Hua</au><au>Li, Chien-Feng</au><au>Chen, Ying-Yin</au><au>Hsing, Chung-Hsi</au><au>Rezaei, Nima</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-19 in Breast Cancer</atitle><jtitle>Clinical &amp; developmental immunology</jtitle><addtitle>Clin Dev Immunol</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>2013</volume><issue>2013</issue><spage>1</spage><epage>9</epage><pages>1-9</pages><issn>2314-8861</issn><issn>1740-2522</issn><eissn>2314-7156</eissn><eissn>1740-2530</eissn><abstract>Inflammatory cytokines within the tumor microenvironment are linked to progression in breast cancer. Interleukin- (IL-) 19, part of the IL-10 family, contributes to a range of diseases and disorders, such as asthma, endotoxic shock, uremia, psoriasis, and rheumatoid arthritis. IL-19 is expressed in several types of tumor cells, especially in squamous cell carcinoma of the skin, tongue, esophagus, and lung and invasive duct carcinoma of the breast. In breast cancer, IL-19 expression is correlated with increased mitotic figures, advanced tumor stage, higher metastasis, and poor survival. The mechanisms of IL-19 in breast cancer have recently been explored both in vitro and in vivo. IL-19 has an autocrine effect in breast cancer cells. It directly promotes proliferation and migration and indirectly provides a microenvironment for tumor progression, which suggests that IL-19 is a prognostic marker in breast cancer and that antagonizing IL-19 may have therapeutic potential.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>23710200</pmid><doi>10.1155/2013/294320</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2314-8861
ispartof Clinical & developmental immunology, 2013-01, Vol.2013 (2013), p.1-9
issn 2314-8861
1740-2522
2314-7156
1740-2530
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_06f30df2f2eb4e25a94377784c85751e
source PubMed Central database; Wiley Open Access; ProQuest Publicly Available Content database
subjects Biomarkers - metabolism
Breast cancer
Breast Neoplasms - diagnosis
Breast Neoplasms - immunology
Breast Neoplasms - mortality
Breast Neoplasms - pathology
Carcinoma, Ductal, Breast - diagnosis
Carcinoma, Ductal, Breast - immunology
Carcinoma, Ductal, Breast - mortality
Carcinoma, Ductal, Breast - pathology
Cell Movement
Cell Proliferation
Colleges & universities
Disease Progression
Female
Gene Expression
Humans
Immunology
Interleukins - genetics
Interleukins - immunology
Neoplasm Metastasis
Prognosis
Review
Rodents
Survival Analysis
Tumor Microenvironment - immunology
Tumors
title Interleukin-19 in Breast Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T10%3A09%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-19%20in%20Breast%20Cancer&rft.jtitle=Clinical%20&%20developmental%20immunology&rft.au=Chang,%20Ming-Shi&rft.date=2013-01-01&rft.volume=2013&rft.issue=2013&rft.spage=1&rft.epage=9&rft.pages=1-9&rft.issn=2314-8861&rft.eissn=2314-7156&rft_id=info:doi/10.1155/2013/294320&rft_dat=%3Cproquest_doaj_%3E1508758755%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c664t-f58ff7aaf88b6e6c81fe3d80e90ea047fb13b4e9a16ada362d573099a25392d83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1428011736&rft_id=info:pmid/23710200&rfr_iscdi=true